Original Article

An In Silico Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients
  • Daniel Rodrigues de Bastos
  • Mércia Patrícia Ferreira Conceição
  • Ana Paula Picaro Michelli
  • Jean Michel Rocha Sampaio Leite
  • Rafael André da Silva
  • Ricardo Cesar Cintra
  • Jeniffer Johana Duarte Sanchez
  • Cesar Augusto Sam Tiago Vilanova-Costa
  • Antonio Márcio Teodoro Cordeiro Silva
Eur J Breast Health 2021; 17: 42-52 DOI: 10.4274/ejbh.2020.5804 PMID:33796830

Review

Breast Cancer Prevention: Current Approaches and Future Directions
  • Edward R. Sauter
Eur J Breast Health 2018; 14: 64-71 DOI: 10.5152/ejbh.2018.3978
Reliable Biomarkers to Identify New and Recurrent Cancer
  • Edward R. Sauter
Eur J Breast Health 2017; 13: 162-167 DOI: 10.5152/ejbh.2017.3635
American Joint Committee on Cancer’s Staging System for Breast Cancer, Eighth Edition: Summary for Clinicians
  • Haoling Zhu
  • Başak E. Doğan
Eur J Breast Health 2021; 17: 234-238 DOI: 10.4274/ejbh.galenos.2021.2021-4-3 PMID:34263150